Diabetes device registry launches to track 5-Year patient outcomes

NCT ID NCT07197775

Summary

This registry aims to collect long-term safety and health outcome information from people with type 2 diabetes who have already been treated with the Endogenex System. It will follow up to 500 participants for five years to monitor their health after the procedure. The goal is to gather real-world data to better understand the long-term effects of this treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.